Morphine
Morphine is a strong opioid painkiller derived from the opium poppy; like all opioids it can suppress breathing, cause dependence, and be fatal in overdose.
Overview
Morphine is a naturally occurring opioid extracted from the opium poppy, and it remains one of the most important medicines for treating moderate-to-severe pain — for example after surgery, during cancer care, or in palliative settings. It is the reference drug against which other opioids' potency is measured. Because it is a strong opioid, it carries the same core dangers as the rest of the class: it can suppress breathing, it produces tolerance and physical dependence with repeated use, and it can be fatal in overdose. Most morphine use is medical and supervised, but it is also misused, and like other prescription opioids it appears on the illicit market — where, as with all street opioids, there is a risk that what is sold as one thing is actually mixed with or replaced by fentanyl.
Source: MedlinePlus; DEA; PubChem CID 5288826
Chemistry & mechanism of action
Morphine is an opioid agonist: it binds to and activates mu-opioid receptors in the brain and spinal cord, blocking the transmission of pain signals and producing pain relief along with sedation and, often, a sense of euphoria. Activating these receptors also triggers dopamine release that reinforces repeated use, and — critically — it suppresses the brain-stem centers that control breathing. That respiratory depression is how opioid overdose kills. With repeated use the body adapts, so more is needed for the same effect (tolerance) and the body comes to depend on the drug's presence (physical dependence); stopping then brings withdrawal. Tolerance to the breathing-suppressing effect lags behind tolerance to the desired effects, which is part of why dose escalation is dangerous.
Source: MedlinePlus; PubChem CID 5288826
Effects
At therapeutic doses morphine relieves pain and commonly causes drowsiness, a sense of calm or euphoria, constipation, nausea, dry mouth, sweating, and small (constricted) pupils. As the dose rises, the dangerous effects emerge: heavy sedation, confusion, and breathing that becomes slow and shallow or stops. With repeated use, tolerance and physical dependence develop, and stopping after regular use brings an opioid withdrawal syndrome — muscle and bone aches, restlessness, insomnia, sweating, nausea, vomiting, diarrhea, and strong cravings — deeply unpleasant but not usually directly life-threatening on its own. Dependence can develop even with appropriate prescribed use and is distinct from addiction, though it can contribute to it.
Source: MedlinePlus
Risks & harms
Morphine's central danger is respiratory depression: too much slows or stops breathing, and the margin narrows sharply with higher doses, with reduced tolerance (for example after a period of not using), and when morphine is combined with other depressants. Mixing morphine with alcohol, benzodiazepines, or other opioids compounds the suppression of breathing and is a frequent factor in fatal overdoses. Overdose presents as unresponsiveness, slow or stopped breathing, gurgling or snoring sounds, pinpoint pupils, and blue or grey lips or fingertips. Naloxone (Narcan) reverses an opioid overdose, is available over the counter in the U.S. since 2023, and is safe to give even if opioids turn out not to be the cause — give it if available and call 911 immediately. On the illicit market, anything sold as morphine carries the added risk of fentanyl contamination, which can make a dose far stronger than expected. For poisoning guidance call Poison Control at 1-800-222-1222; for substance-use support the SAMHSA National Helpline is 1-800-662-4357.
Source: MedlinePlus; DEA; SAMHSA
Legal status (US)
In the United States, morphine is a Schedule II controlled substance under the Controlled Substances Act: it has accepted medical uses but a high potential for abuse and dependence, so it is tightly regulated, prescriptions cannot be refilled, and distribution outside the medical system is a serious federal offense. Internationally, morphine is controlled under the United Nations Single Convention on Narcotic Drugs, and it is simultaneously recognized by the World Health Organization as an essential medicine for pain relief — so most countries permit its medical use while strictly controlling it. Penalties for unlawful possession or supply vary widely by country. For country-by-country legal detail, see our legality pages.
Source: DEA; UN Single Convention on Narcotic Drugs (1961); WHO
Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling — penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authorityand your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulatein the destination immediately — notthe destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
With opioids, slowed or stopped breathing is the emergency — if available, give naloxone and call 911 immediately; it can be given while you wait for help.
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown — pending review”Identity
- PubChem CID
- 5288826PubChem PUG-REST ↗ · retrieved 2026-06-18
- IUPAC name
- (4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diolPubChem PUG-REST ↗ · retrieved 2026-06-18
- Molecular formula
- C17H19NO3PubChem PUG-REST ↗ · retrieved 2026-06-18
- SMILES
- CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)OPubChem PUG-REST ↗ · retrieved 2026-06-18
- InChIKey
- BQJCRHHNABKAKU-KBQPJGBKSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
- Synonyms / aliases
- Morphia, Morphium, Morphina, (-)-Morphine, Morphinum, Ospalivina, Morphin, Duromorph, Meconium, MorphinismPubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18
Composition
- Composition
- N/A — single compound (see Identity)
Physical / pill characteristics
- Dosage form
- 3 DOSAGE FORMS AND STRENGTHS Morphine sulfate tablets 15 mg: Each tablet contains 15 mg morphine sulfate, USP (equivalent to 11.25 mg morphine) and is a white, openFDA drug label ↗ · retrieved 2026-06-18
- Shape
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Color
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Imprint
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Score
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- Unknown — pending review
Pill catalog
Rx/OTC variants · openFDA + DailyMed (public domain) · draft, pending reviewThis drug comes in 86different versions. Make sure you’re looking at the right one — use the search above to find your exact pill by imprint, color, or shape.
Showing 86 of 86 variants
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- American Health Packaging
- Schedule
- CII
- NDC
- 68084-158 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 60 mg/1
- Imprint
- RD72
- Color
- orange
- Shape
- ROUND
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Schedule
- CII
- NDC
- 63304-758 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- American Health Packaging
- Schedule
- CII
- NDC
- 68084-157 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 10 mg/1
- Imprint
- UPSHER SMITH 0225 10 mg
- Color
- blue
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Upsher-Smith Laboratories, LLC
- Schedule
- CII
- NDC
- 0832-0225 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- 54 262
- Color
- WHITE
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Schedule
- CII
- NDC
- 0054-0236 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 60 mg/1
- Imprint
- M 60
- Color
- orange
- Shape
- ROUND
- Form
- TABLET, EXTENDED RELEASE
- Labeler
- SpecGx LLC
- Schedule
- CII
- NDC
- 0406-8380 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- RD70
- Color
- blue
- Shape
- ROUND
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Schedule
- CII
- NDC
- 63304-450 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- RD71
- Color
- purple
- Shape
- ROUND
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Schedule
- CII
- NDC
- 63304-451 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- 271
- Color
- yellow
- Shape
- ROUND
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Actavis Pharma, Inc.
- Schedule
- CII
- NDC
- 0228-4271 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 20 mg/1
- Imprint
- UPSHER SMITH 0226 20 mg
- Color
- yellow
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Upsher-Smith Laboratories, LLC
- Schedule
- CII
- NDC
- 0832-0226 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 100 mg/1
- Imprint
- RD73
- Color
- gray
- Shape
- ROUND
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Schedule
- CII
- NDC
- 63304-452 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 100 mg/1
- Imprint
- M 100
- Color
- gray
- Shape
- ROUND
- Form
- TABLET, EXTENDED RELEASE
- Labeler
- SpecGx LLC
- Schedule
- CII
- NDC
- 0406-8390 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 200 mg/1
- Imprint
- RD74
- Color
- green
- Shape
- OVAL
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Schedule
- CII
- NDC
- 63304-453 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- M30
- Color
- WHITE
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Ascend Laboratories, LLC
- Schedule
- CII
- NDC
- 67877-671 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- M15
- Color
- WHITE
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Ascend Laboratories, LLC
- Schedule
- CII
- NDC
- 67877-670 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 40 mg/1
- Imprint
- J69
- Color
- yellow
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Schedule
- CII
- NDC
- 0115-1479 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- UPSHER SMITH 0227 30 mg
- Color
- blue
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Upsher-Smith Laboratories, LLC
- Schedule
- CII
- NDC
- 0832-0227 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- 3090
- Color
- blue
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Actavis Pharma, Inc.
- Schedule
- CII
- NDC
- 0228-3090 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 200 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 63629-8505 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 63629-4484 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 63629-4483 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 60 mg/1
- Imprint
- 3091
- Color
- green
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Actavis Pharma, Inc.
- Schedule
- CII
- NDC
- 0228-3091 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 50 mg/1
- Imprint
- UPSHER SMITH 0228 50 mg
- Color
- blue
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Upsher-Smith Laboratories, LLC
- Schedule
- CII
- NDC
- 0832-0228 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 60 mg/1
- Imprint
- N 60 mg
- Color
- pink
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Nortec Development Associates, Inc.
- Schedule
- CII
- NDC
- 42689-008 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 200 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 72162-1352 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 20 mg/1
- Imprint
- N 20 mg
- Color
- yellow
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Nortec Development Associates, Inc.
- Schedule
- CII
- NDC
- 42689-005 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 60 mg/1
- Imprint
- UPSHER SMITH 0229 60 mg
- Color
- pink
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Upsher-Smith Laboratories, LLC
- Schedule
- CII
- NDC
- 0832-0229 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- N 30 mg
- Color
- blue
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Nortec Development Associates, Inc.
- Schedule
- CII
- NDC
- 42689-006 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 50 mg/1
- Imprint
- N 50 mg
- Color
- blue
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Nortec Development Associates, Inc.
- Schedule
- CII
- NDC
- 42689-007 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 100 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 71335-3080 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 80 mg/1
- Imprint
- N 80 mg
- Color
- yellow
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Nortec Development Associates, Inc.
- Schedule
- CII
- NDC
- 42689-009 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 100 mg/1
- Imprint
- N 100 mg
- Color
- green
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Nortec Development Associates, Inc.
- Schedule
- CII
- NDC
- 42689-010 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 80 mg/1
- Imprint
- UPSHER SMITH 0230 80 mg
- Color
- orange
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Upsher-Smith Laboratories, LLC
- Schedule
- CII
- NDC
- 0832-0230 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 120 mg/1
- Imprint
- 3093
- Color
- blue
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Actavis Pharma, Inc.
- Schedule
- CII
- NDC
- 0228-3093 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 100 mg/1
- Imprint
- UPSHER SMITH 0233 100 mg
- Color
- green
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Upsher-Smith Laboratories, LLC
- Schedule
- CII
- NDC
- 0832-0233 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 45 mg/1
- Imprint
- 3116
- Color
- purple
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Actavis Pharma, Inc.
- Schedule
- CII
- NDC
- 0228-3116 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 60 mg/1
- Imprint
- n 60
- Color
- ORANGE
- Shape
- ROUND
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Lupin Pharmaceuticals,Inc.
- Schedule
- CII
- NDC
- 43386-542 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- n 15
- Color
- BLUE
- Shape
- ROUND
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Lupin Pharmaceuticals,Inc.
- Schedule
- CII
- NDC
- 43386-540 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- n 30
- Color
- PURPLE
- Shape
- ROUND
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Lupin Pharmaceuticals,Inc.
- Schedule
- CII
- NDC
- 43386-541 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 100 mg/1
- Imprint
- N 100
- Color
- GRAY
- Shape
- ROUND
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Lupin Pharmaceuticals,Inc.
- Schedule
- CII
- NDC
- 43386-543 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 200 mg/1
- Imprint
- n 200
- Color
- GREEN
- Shape
- CAPSULE
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Lupin Pharmaceuticals,Inc.
- Schedule
- CII
- NDC
- 43386-544 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- 15 273
- Color
- white
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Upsher-Smith Laboratories, LLC
- Schedule
- CII
- NDC
- 0832-0273 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 75 mg/1
- Imprint
- 3117
- Color
- brown
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Actavis Pharma, Inc.
- Schedule
- CII
- NDC
- 0228-3117 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 72162-1790 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 72162-1789 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 20 mg/1
- Imprint
- J62
- Color
- yellow
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Schedule
- CII
- NDC
- 0115-1277 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- 30 274
- Color
- white
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Upsher-Smith Laboratories, LLC
- Schedule
- CII
- NDC
- 0832-0274 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 100 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 72162-1791 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 200 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 72162-1792 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 60 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 72162-1793 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- PF M15
- Color
- BLUE
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Rhodes Pharmaceuticals LLC
- Schedule
- CII
- NDC
- 42858-515 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- RedPharm Drug, Inc.
- Schedule
- CII
- NDC
- 67296-1753 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- J63
- Color
- purple
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Schedule
- CII
- NDC
- 0115-1278 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- PF M30
- Color
- PURPLE
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Rhodes Pharmaceuticals LLC
- Schedule
- CII
- NDC
- 42858-631 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Major Pharmaceuticals
- Schedule
- CII
- NDC
- 0904-6557 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 50 mg/1
- Imprint
- J64
- Color
- blue
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Schedule
- CII
- NDC
- 0115-1279 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Major Pharmaceuticals
- Schedule
- CII
- NDC
- 0904-6558 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- ABG 30
- Color
- PURPLE
- Shape
- ROUND
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Rhodes Pharmaceuticals LLC
- Schedule
- CII
- NDC
- 42858-802 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 60 mg/1
- Imprint
- PF M60
- Color
- ORANGE
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Rhodes Pharmaceuticals LLC
- Schedule
- CII
- NDC
- 42858-760 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 60 mg/1
- Imprint
- J65
- Color
- red
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Schedule
- CII
- NDC
- 0115-1280 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- ABG 15
- Color
- BLUE
- Shape
- ROUND
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Rhodes Pharmaceuticals LLC
- Schedule
- CII
- NDC
- 42858-801 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 60 mg/1
- Imprint
- ABG 60
- Color
- ORANGE
- Shape
- ROUND
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Rhodes Pharmaceuticals LLC
- Schedule
- CII
- NDC
- 42858-803 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 100 mg/1
- Imprint
- ABG 100
- Color
- GRAY
- Shape
- ROUND
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Rhodes Pharmaceuticals LLC
- Schedule
- CII
- NDC
- 42858-804 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 200 mg/1
- Imprint
- ABG 200
- Color
- GREEN
- Shape
- CAPSULE
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Rhodes Pharmaceuticals LLC
- Schedule
- CII
- NDC
- 42858-805 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 60 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Major Pharmaceuticals
- Schedule
- CII
- NDC
- 0904-6559 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 80 mg/1
- Imprint
- J66
- Color
- orange
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Schedule
- CII
- NDC
- 0115-1281 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 100 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Major Pharmaceuticals
- Schedule
- CII
- NDC
- 0904-6560 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 100 mg/1
- Imprint
- J67
- Color
- green
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Schedule
- CII
- NDC
- 0115-1282 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- 54 733
- Color
- WHITE
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Schedule
- CII
- NDC
- 0054-0235 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 90 mg/1
- Imprint
- 3092
- Color
- green
- Shape
- CAPSULE
- Form
- CAPSULE, EXTENDED RELEASE
- Labeler
- Actavis Pharma, Inc.
- Schedule
- CII
- NDC
- 0228-3092 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Redpharm Drug
- Schedule
- CII
- NDC
- 67296-2122 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 71335-9662 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- American Health Packaging
- Schedule
- CII
- NDC
- 60687-617 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 60 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 63629-1089 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 63629-1087 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 63629-1088 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 71335-0676 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 200 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 63629-1091 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- M 15
- Color
- blue
- Shape
- ROUND
- Form
- TABLET, EXTENDED RELEASE
- Labeler
- SpecGx LLC
- Schedule
- CII
- NDC
- 0406-8315 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 60 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 71335-0707 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 71335-0736 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Bryant Ranch Prepack
- Schedule
- CII
- NDC
- 63629-8459 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 15 mg/1
- Imprint
- M 15
- Color
- white
- Shape
- ROUND
- Form
- TABLET
- Labeler
- SpecGx LLC
- Schedule
- CII
- NDC
- 0406-5118 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 200 mg/1
- Imprint
- M 200
- Color
- green
- Shape
- OVAL
- Form
- TABLET, EXTENDED RELEASE
- Labeler
- SpecGx LLC
- Schedule
- CII
- NDC
- 0406-8320 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- M 30
- Color
- purple
- Shape
- ROUND
- Form
- TABLET, EXTENDED RELEASE
- Labeler
- SpecGx LLC
- Schedule
- CII
- NDC
- 0406-8330 ↗ · 2026-06-18
- Strength
- MORPHINE SULFATE 30 mg/1
- Imprint
- M 30
- Color
- white
- Shape
- ROUND
- Form
- TABLET
- Labeler
- SpecGx LLC
- Schedule
- CII
- NDC
- 0406-5119 ↗ · 2026-06-18
Dosage
Pending medical reviewer
